South Korea’s SK Bioscience’s Andong base responsible for producing Covid-19 vaccines of AstraZeneca and Novavax has earned Good Manufacturing Practices (GMP) certification from the European Union authority, making its output eligible for shipments across Europe.
The Korean company said Monday its production facility and process and quality systems to manufacture the coronavirus jabs at its vaccine plant, L House, in Andong, Gyeongbuk Province won EU-GMP certification, which requires strict management standards for all processes from purchasing of raw materials to manufacturing, quality control, and shipment to ensure safe and effective pharmaceuticals. Next news.
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]
[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]